- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 3 residues within 4Å:- Chain A: N.301, V.313, N.314
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.8: 3 residues within 4Å:- Chain E: N.301, V.313, N.314
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.12: 3 residues within 4Å:- Chain I: N.301, V.313, N.314
No protein-ligand interaction detected (PLIP)- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.13: 1 residues within 4Å:- Chain A: N.38
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain A: E.78, N.79, K.108, Y.110
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.142, T.144
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.149
Ligand excluded by PLIPNAG.17: 5 residues within 4Å:- Chain B: A.147, G.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain E: N.38
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain E: E.78, N.79, K.108, Y.110
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain E: N.142, T.144
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain E: N.149
Ligand excluded by PLIPNAG.22: 5 residues within 4Å:- Chain F: A.147, G.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain I: N.38
Ligand excluded by PLIPNAG.24: 4 residues within 4Å:- Chain I: E.78, N.79, K.108, Y.110
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain I: N.142, T.144
Ligand excluded by PLIPNAG.26: 1 residues within 4Å:- Chain I: N.149
Ligand excluded by PLIPNAG.27: 5 residues within 4Å:- Chain J: A.147, G.150, S.151, N.154, T.156
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chuang, G.Y. et al., Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses. Front Immunol (2021)
- Release Date
- 2021-05-12
- Peptides
- Hemagglutinin: AEI
Fusion protein of Hemagglutinin and Envelope glycoprotein: BFJ
Fab heavy chain: CGK
Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
GB
BF
DJ
IC
HG
EK
JD
LH
FL
K
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 15 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Chuang, G.Y. et al., Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A Viruses. Front Immunol (2021)
- Release Date
- 2021-05-12
- Peptides
- Hemagglutinin: AEI
Fusion protein of Hemagglutinin and Envelope glycoprotein: BFJ
Fab heavy chain: CGK
Fab light chain: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AE
CI
GB
BF
DJ
IC
HG
EK
JD
LH
FL
K